The grey market premium of Senores Pharmaceuticals was Rs 220 as of 4:28 p.m. on Monday, according to Chittorgarh's unit ...

Senores Pharmaceuticals' initial public offering garnered 13.88 times subscription on Monday, the day two of bidding.

Retail investors subscribed to the issue 38.34 times, while non-institutional investors (NIIs) subscribed 24.48 times.

Senores Pharmaceutical IPO opened for subscription on 20th December 2024, and will remain open for subscription till December ...

Senores Pharmaceuticals' IPO witnessed an impressive 13.88 times subscription, amassing bids for 11.8 crore shares compared ...

The Senores Pharmaceuticals’ public issue will close for public bidding on Tuesday, December 24. The IPO has received 1.78x ...

Senores Pharmaceuticals' IPO received 13.88 times subscription on Day 2, with strong demand from retail and institutional ...

Choose between Carraro India with its strong growth or Senores Pharma with high market demand. Decide your bet by!

Senores Pharmaceuticals IPO receives strong response on Day 1, with retail investors leading the way, closing on4.

Senores Pharmaceuticals Ltd. opened for day two of subscription on Monday. The Rs 582.11-crore offering consists of a fresh issue of Rs 500 crore and an offer for sale of Rs 82.11 crore. It has been ...

Proceeds from the fresh issue will be used for setting up a manufacturing facility for production of sterile injections in ...

Ahead of the IPO, Senores Pharmaceuticals on Thursday, 19 December 2024, raised Rs 260.62 crore from anchor investors. The board allotted 66.65 lakh shares at Rs 391 each to 20 anchor investors.